financetom
Business
financetom
/
Business
/
Consumption slows compared to September quarter, rural volumes under pressure: NeilsenIQ update
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Consumption slows compared to September quarter, rural volumes under pressure: NeilsenIQ update
Feb 2, 2023 7:07 AM

The Indian fast-moving consumer goods (FMCG) industry has seen a decline in growth in the December quarter of the calendar year 2022 due to a slump in rural demand, according to Nielsen IQ’s report. The industry witnessed a growth of 7.6 percent in the December quarter, which is much lower than the 9.2 percent seen in the preceding quarter.

Share Market Live

NSE

The report also said that the industry witnessed a price growth of 7.9 percent in the December quarter as compared to 9.9 percent a year earlier.

In the December quarter, volume growth in the FMCG sector dropped 0.3 percent, compared with a 0.6 percent decline over the previous quarter.

The rural market, which contributes nearly 35 percent of the total FMCG sales, saw its volume declining 2.8 percent, in contrast, urban volumes rose 1.6 percent.

Although overall FMCG volume growth was negative in the December quarter, absolute values as well as volumes were above pre-pandemic levels, the report pointed out.

Traditional trade has seen a 1.5 percent volume degrowth in the December quarter, making it the fifth straight quarter of decline, while modern trade maintained a double-digit value growth at 23.3 percent.

In terms of segments, the food segment performed well compared to the non-food space in the December quarter. The food sector has seen a growth of 8.6 percent in the December quarter and volume in the space rose 1.6 percent. The non-food space has witnessed a 7.4 percent growth while the volume dropped by 4.6 percent.

(Edited by : Rukmani Krishna)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved